How does fvg look like

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Klovinal is a brand name for a combination medication containing two active ingredients: diclofenac potassium and chlorzoxazone. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), and chlorzoxazone is a muscle relaxant. Both of these drug classes are generally advised against or require extreme caution during pregnancy due to potential risks to the developing fetus. Therefore, it is generally not considered safe to use Klovinal during pregnancy without explicit medical supervision and a clear indication of benefit outweighing the risk by a healthcare professional.

Key Facts

Klovinal contains diclofenac potassium (an NSAID) and chlorzoxazone (a muscle relaxant).
NSAIDs like diclofenac are generally contraindicated in the third trimester of pregnancy due to risks of premature closure of the ductus arteriosus.
Chlorzoxazone's safety profile during pregnancy is not well-established, and it is typically avoided unless absolutely necessary.
Potential risks associated with NSAIDs in pregnancy include miscarriage, birth defects, and complications during labor and delivery.
The use of any prescription medication during pregnancy requires careful evaluation by a healthcare provider.

Overview

Pregnancy is a unique physiological state where the body undergoes significant changes to support fetal development. During this time, the use of any medication, including over-the-counter and prescription drugs, warrants careful consideration due to potential implications for both the mother and the unborn child. Many common medications that are safe for non-pregnant individuals can pose risks during gestation, necessitating a thorough risk-benefit analysis before initiation.

Klovinal is a combination medication that brings together two active pharmaceutical ingredients: diclofenac potassium and chlorzoxazone. Diclofenac potassium belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs), commonly used to alleviate pain and reduce inflammation. Chlorzoxazone is a centrally acting muscle relaxant, prescribed to relieve muscle spasms and associated discomfort. The combined action of these two drugs aims to address pain and muscle stiffness, often seen in musculoskeletal conditions.

How Klovinal Works

Diclofenac Potassium: This component works by inhibiting cyclooxygenase (COX) enzymes, which are responsible for the synthesis of prostaglandins. Prostaglandins are signaling molecules that play a crucial role in inflammation, pain, and fever. By reducing prostaglandin production, diclofenac effectively reduces these symptoms. It is a potent anti-inflammatory agent and analgesic.
Chlorzoxazone: This muscle relaxant acts on the central nervous system, primarily at the level of the spinal cord and subcortical areas of the brain. It interrupts the transmission of nerve impulses that cause muscle spasms, leading to relaxation of the affected muscles. This helps to relieve pain and improve mobility associated with muscle strain or injury.
Synergistic Effect: The combination of diclofenac and chlorzoxazone in Klovinal is designed to provide comprehensive pain relief by addressing both the inflammatory and muscular components of pain. This can be particularly beneficial for conditions that involve both inflammation and muscle spasm, such as acute back pain, sprains, and strains.
Mechanism of Action Summary: In essence, Klovinal targets pain and discomfort through two distinct but complementary pathways: reducing inflammation and pain signaling via NSAID action, and alleviating muscle tightness through central muscle relaxation.

Key Comparisons: NSAIDs and Muscle Relaxants in Pregnancy

Consideration	NSAIDs (e.g., Diclofenac)	Muscle Relaxants (e.g., Chlorzoxazone)	Klovinal (Combination)
Third Trimester Risk	High risk; premature closure of ductus arteriosus, pulmonary hypertension.	Data is limited, but caution is advised.	High risk; inherits risks from diclofenac.
First Trimester Risk	Potential increased risk of miscarriage and certain birth defects (e.g., cardiac defects).	Data is limited; generally avoided.	High risk; inherits risks from diclofenac.
Overall Safety Data	Extensive data available, showing significant risks during specific trimesters.	Limited robust data for pregnant populations.	Combination data is scarce; risks inferred from individual components.
General Recommendation	Avoid, especially in the third trimester; use only if absolutely necessary and under strict medical guidance.	Avoid unless benefits clearly outweigh potential risks.	Strongly advised against without thorough medical consultation.

Why It Matters

The use of Klovinal during pregnancy is a serious concern due to the potential for adverse effects on the developing fetus. The medications within Klovinal, specifically diclofenac, have known teratogenic potential or can cause significant complications during different stages of pregnancy. For instance, NSAIDs, including diclofenac, can lead to premature closure of the ductus arteriosus, a vital fetal blood vessel, particularly during the third trimester. This can result in pulmonary hypertension and heart problems in the newborn. Furthermore, NSAID use in early pregnancy has been linked to an increased risk of miscarriage and certain congenital malformations, such as cardiac defects.

The safety profile of chlorzoxazone in pregnant individuals is not as extensively studied as that of NSAIDs. However, as a general principle, medications that act on the central nervous system are approached with caution during pregnancy. Without sufficient evidence demonstrating its safety, chlorzoxazone is typically avoided unless other, safer alternatives are ineffective and the perceived benefit to the mother is substantial. The combination of these two agents in Klovinal amplifies the need for extreme caution, as the risks associated with each component may be present.

The decision to use any medication during pregnancy, especially one like Klovinal with known or suspected risks, must be made in consultation with a qualified healthcare provider. They will assess the pregnant individual's specific condition, the severity of symptoms, the gestational age, and consider available safer alternatives. Self-medication with Klovinal or any prescription drug during pregnancy is strongly discouraged. Healthcare professionals will weigh the potential benefits of symptom relief against the potential risks to the fetus and mother, making an informed recommendation based on the best available evidence and individual circumstances.